1-β-D-arabinofuranosylcytosine inhibits borna disease virus replication and spread

Journal of Virology

Volumn 76, Issue 12, 2002, Pages 6268-6276

  Bajramovic, Jeffrey J ^a   Syan, Sylvie ^a   Brahic, Michel ^a   De la Torre, Juan Carlos ^a   Gonzalez Dunia, Daniel ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DNA POLYMERASE; NUCLEOSIDE DERIVATIVE;

ANIMAL CELL; ARTICLE; BORNA DISEASE; BORNA DISEASE VIRUS; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DRUG EFFICACY; HOST CELL; HUMAN; HUMAN CELL; INFLUENZA VIRUS; MEASLES VIRUS; NEUROLOGIC DISEASE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; RNA SYNTHESIS; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS TRANSMISSION; ZOONOSIS;

ANIMALS; ANTIVIRAL AGENTS; BORNA DISEASE; BORNA DISEASE VIRUS; CELL LINE; CERCOPITHECUS AETHIOPS; CYTARABINE; HIPPOCAMPUS; NEURONS; RATS; RATS, INBRED LEW; VERO CELLS; VIRUS REPLICATION;

EID: 0036106766     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.12.6268-6286.2002     Document Type: Article

References (47)

1. Early and persistent abnormalities in rats with neonatally acquired Borna disease virus infection
2. Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression
3. Boma disease virus-specific circulating immune complexes, antigenemia, and free antibodiesthe key marker triplet determining infection and prevailing in severe mood disorders
4. Borna disease virus genome transcribed and expressed in psychiatric patients
5. Borna disease virus and human disease
6. Borna disease virus replicates in astrocytes, Schwann cells and ependymal cells in persistently infected rats: Location of viral genomic and messenger RNAs by in situ hybridization
7. Borna disease: Association with a maturation defect in the cellular immune response
8. The mechanisms of lethal action of arabinosyl cytosine (araC) and arabinosyl adenine (araA)
9. The mechanism of action of inhibitors of DNA synthesis
10. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
11. Amantadine does not have antiviral activity against Borna disease virus
12. Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present
13. Sequence and genome organization of Borna disease virus
14. Molecular biology of Borna disease virus: Prototype of a new group of animal viruses
15. Detection of Borna disease virus antigen and RNA in human autopsy brain samples from neuropsychiatric patients
16. Learning deficiencies in Borna disease virus-infected but clinically healthy rats
17. Borna disease virus (BDV), a (zoonotic?) worldwide pathogen. A review of the history of the disease and the virus infection with comprehensive bibliography
18. Inhibition of mammalian DNA polymerase by the 5′-triphosphate of 1-beta-D-arabinofuranosylcytosine and the 5′-triphosphate of 9-beta-D-arabinofuranoxyladenine
19. Characterization of Borna disease virus p56 protein, a surface glycoprotein involved in virus entry
20. Rabies and Borna disease. A comparative pathogenetic study of two neurovirulent agents
21. Borna disease neuropathology and pathogenesis
22. Borna disease virus is not sensitive to amantadine
23. Borna disease virus persistent infection activates mitogen-activated protein kinase and blocks neuronal differentiation of PC12 cells
24. Replication of Borna disease virus in cell cultures
25. Inhibition of Borna disease virus replication by ribavirin
26. Demonstration of human Borna disease virus RNA in human peripheral blood mononuclear cells
27. Borna disease virus nucleoprotein requires both nuclear localization and export activities for viral nucleocytoplasmic shuttling
28. Borna disease virus and neuropsychiatric diseasea reappraisal
29. Borna disease virus: Implications for human neuropsychiatric illness
30. Borna disease: A persistent virus infection of the central nervous system
31. Inhibition of Borna disease virus replication by ribavirin in persistently infected cells
32. Enhancement of Borna disease virus transcription in persistently infected cells by serum starvation
33. Isolation of Borna disease virus from human brain tissue
34. Behavioral disease in rats caused by immunopathological responses to persistent Borna virus in the brain
35. Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1
36. Preparation of purified nuclei and nucleoli from mammalian cells
37. Pathogenesis of Borna disease virus: Granulocyte fractions of psychiatric patients harbor infectious virus in the absence of antiviral anti-bodies
38. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
39. Induction of topoisomerase I cleavage complexes by 1-beta-D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells
40. Nuclear retention of IκBα protects it from signal-induced degradation and inhibits nuclear factor κB transcriptional activation
41. Natural and experimental Borna disease in animals
42. Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders
43. The remarkable coding strategy of Borna disease virus: A new member of the nonsegmented negative strand RNA viruses
44. Immunopathogenesis of Borna disease
45. Lack of antiviral effect of amantadine in Borna disease virus infection
46. Antigenic relationship and further characterization of two major Borna disease virus-specific proteins
47. Inhibition of DNA polymerase-alpha and -beta of calf thymus by 1-beta-D-arabinofuranosylcytosine-5′-triphosphate